Conclusion Of A Non-Exclusive Discount Agreement In Accordance With § 130A Paragraph 8 Sgb V For The Active Ingredient Melatonin (Exclusively In The Strengths 1 Mg And 5 Mg), Atc N05Ch01 For The Period August 1St, 2023 - July 31St, 2025

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 67734330

  Document Type - Tender Notices

Description - § 130a paragraph 8 SGB V enables the health insurance companies and pharmaceutical companies to conclude framework discount agreements for the drugs to be supplied at the expense of the statutory health insurance companies. With regard to the releva nt legal regulations for the award of public contracts, a regular process of active ingredient-related, formal award procedures takes place according to the regulations of the 4th part of the GWB by the DAK-Gesundheit. For pharmaceuticals to be specified by the bidder in Annex 2 to the contract for the above-mentioned active ingredient melatonin (exclusively in the strengths 1 mg and 5 mg), ATC N05CH01, DAK-Gesundheit intends to conclude drug dis

Gt Ref Id - 67734330

Deadline - Jun 05, 2025